Highlights
- 1Brain communications · 2023
- 2Journal of Alzheimer's disease reports · 2024
- 3AJNR. American journal of neuroradiology · 2023
Publications
110 publications
Funding
23 grantsView NIH portfolio on RePORTER ↗
Active
13 grants- PIR01AG096446-01A1Understanding Psychosis Heterogeneity In Late Life (UPHILL)National Institute on Aging · 2026–2031
- PIHT9425-25-1-0789Circulating Antibody Repertoire And Blood-Brain-Barrier Impairment to explain NEuRopsychiatric symptoms of "invisible" brain injuryU.S. Department of Defense · 2025–2029
- Co-IU01AG082845-01A1Prism-PET/EMMT: High resolution, cost effective, portable, and upright brain PET scanner for early diagnosis of Alzheimer's diseaseNational Institute on Aging · 2024–2029
- MPIR01AG085972-01A1Tau progression index (TPI): An individualized predictor of Alzheimer's Disease trajectory based on subject-specific connectomesNational Institute on Aging · 2024–2029
- MPIR01AG077576-03Brain fluid clearance and misfolded protein dynamics following traumatic brain injuryNational Institute on Aging · 2023–2029
- Co-IR01AG080011-04Quantitative MRI-based cerebral oxygen metabolism in Alzheimer's diseaseNational Institute on Aging · 2023–2028
- PIWHDF 243779-01Chemokine Receptor Inhibition for Alzheimer's DiseaseWilliam H. Donner Foundation · 2024–2027
- MPIR01AG072753-05Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's DiseaseNational Institute on Aging · 2021–2027 · via Columbia University· 2 renewals
- Co-IR01HL 111724-09Anatomy of the circle of Willis, cerebral blood flow, and Alzheimer's disease biomarkers in hypertensionNational Heart, Lung, and Blood Institute · 2022–2027
- PIWDF 255568-01Leronlimab in Alzheimer's DiseaseWilliam H. Donner Foundation · 2025–2027
- KPS10OD034271-01New PET/CT System for Human and Non-human Primate ImagingOffice of the Director, NIH · 2023–2026
- KPR01AG063846-01A1Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive DysfunctionNational Institute on Aging · 2020–2026
Completed grants (10)
- Co-IR01AG057848-02CSF Clearance in Sporadic Alzheimer's DiseaseNational Institute on Aging · 2019–2025
- Co-IR01NS104364-02Hypertension, brain clearance and markers of neurodegenerationNational Institute of Neurological Disorders and Stroke · 2019–2025
- KPS10OD027039-01A17T Magnetic Resonance Imaging System for Basic, Translational and Clinical ResearchOffice of the Director, NIH · 2021–2025
- Co-IR01AG057962-03Functional Connectivity Network in default mode regions provides the underlying infrastructure for task-based functional co-de/activation networksNational Institute on Aging · 2020–2024
- PIR56NS111052-01CSF clearance and brain amyloid dynamics after traumatic brain injuryNational Institute of Neurological Disorders and Stroke · 2019–2023
- Co-IR56AG058913-02CSF Clearance with 11C-Butanol PET Predicts Amyloid DepositionNational Institute on Aging · 2020–2022
- Co-IRF1AG057570-02PET Measures of CSF Clearance in Preclinical Alzheimer's DiseaseNational Institute on Aging · 2019–2022
- Co-IR56AG064873-01Understanding the dynamic interactions between tau pathology and microglia-mediated inflammation in Alzheimer's DiseaseNational Institute on Aging · 2019–2021
Clinical research
7 studies
Active
5 studies- PINCT07553338Safety Assessment of Leronlimab and Its Effect on Neuroinflammation Targets in Alzheimer's DiseasePHASE2 · Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease; Alzheimer's Disease
- PIUPHILL: Understanding Psychosis Heterogeneity in Late LifeWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)
- PIImaging biodistribution of 11C PK11195 using PETNew York University School of Medicine · OPEN TO ACCRUAL (as of 2021)
- PIMultimodal neuroimaging in traumatic brain injuryWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)
- PIUnderstanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's DiseaseWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)
Completed & closed trials (2)
- PINCT03649724The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer'sPHASE2 · Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)Alzheimer Disease; Mild Cognitive Impairment
- PINCT04426539New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study - A Study to Improve Precision in Amyloid PET Coverage and Patient CareAmerican College of Radiology · IRB STUDY CLOSURE (as of 2023)Alzheimer's Disease; Dementia; Mild Cognitive Impairment
Mentoring
4 menteesAll publications with mentees →
- IOIlker OzsahinPostdoc mentee · 2022–2024
- EGErika GlaubitzMD mentee · Class of 2024
- CSCheyenne SmithMD mentee · Class of 2022
External relationships
Other
Stryder Corp. d/b/a Handshake